Other

Chaoyang University of Technology

Phytohealth Corporation

Kaiyew Investment Corp.

Jenisa Biotechnology Corp.

Chi-Tai Yeh

Yew-Min Tzeng

Chun-Hung Wu

Yu-Wen Liu

Zhen Yang

Hang Shi

Chi-Ying Huang

Yi-Li Lee

Chuang-Chuang Li

Liang-Shun Wang

Tuo-Ping Luo

Tien-Shen Yang

Disclosed is a method for enhancing the effect of an immunotherapy for cancer in a subject, comprising administering to the subject an effective amount of a polysaccharide extract of. Also disclosed is a method for increasing a subject's pool of M1 macrophages, wherein the subject is suffering from one or more conditions associated with undesirable M2 macrophage activation, the method comprising administering to the subject an effective amount of a polysaccharide extract of

Method for enhancing effect of immunotherapy for cancer

The present invention provides a method for inhibiting the growth of cancer stem cells, particularly colorectal cancer stem cells, liver cancer stem cells, lung cancer stem cells or breast cancer stem cells, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of antimycin A or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.

Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer

The present invention provides a method for preparing antrocin of pharmaceutically acceptable salts thereof via a series of gold-catalyzed cyclization to construct the (6-6-5) tricyclic core frame. The present invention also provides a use of a composition in preparing drugs for suppressing growth of non-small cell lung cancer cells, wherein the composition comprises an effective amount of antrocin or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier.

Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer

This subject invention is directed to a method for inhibition of cancer cells, comprising administrating an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, wherein the cancer cells are selected from colorectal cancer cells, liver cancer cells, lung cancer cells or breast cancer cells.

Antrocin containing pharmaceutical compositions for inhibiting cancer cells

Growing community of inventors

Taipei, Taiwan

Chi-Tai Yeh